Radiopharm Theranostics 

$0.010000
8
+$0.00+0% Tuesday 20:00

Statistics

Day High
0.02
Day Low
0.02
52W High
0.02
52W Low
0.01
Volume
25,000
Avg. Volume
158
Mkt Cap
144,584.98
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

28AugExpected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.08
-0.05
-0.03
0
Expected EPS
-0.007562658303148509
Actual EPS
-0.007562658303148509

Financials

-16,217.19%Profit Margin
Unprofitable
2020
2021
2022
2023
199,576.52Revenue
-32.37MNet Income

Analyst Ratings

16.00Average Price Target
The highest estimate is 16.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RDPTF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.
Show more...
CEO
Riccardo Canevari
Employees
14
Country
Australia
ISIN
AU0000181851

Listings

0 Comments

Share your thoughts

FAQ

What is Radiopharm Theranostics stock price today?
The current price of RDPTF is $0.01 USD — it has increased by +0% in the past 24 hours. Watch Radiopharm Theranostics stock price performance more closely on the chart.
What is Radiopharm Theranostics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Radiopharm Theranostics stocks are traded under the ticker RDPTF.
Is Radiopharm Theranostics stock price growing?
RDPTF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Radiopharm Theranostics has showed a -50% decrease.
What is Radiopharm Theranostics market cap?
Today Radiopharm Theranostics has the market capitalization of 144,584.98
When is the next Radiopharm Theranostics earnings date?
Radiopharm Theranostics is going to release the next earnings report on February 26, 2027.
What were Radiopharm Theranostics earnings last quarter?
RDPTF earnings for the last quarter are -0.01 USD per share, whereas the estimation was -0.01 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Radiopharm Theranostics revenue for the last year?
Radiopharm Theranostics revenue for the last year amounts to 199,576.52 USD.
What is Radiopharm Theranostics net income for the last year?
RDPTF net income for the last year is -32.37M USD.
How many employees does Radiopharm Theranostics have?
As of September 04, 2026, the company has 14 employees.
In which sector is Radiopharm Theranostics located?
Radiopharm Theranostics operates in the Health & Wellness sector.
When did Radiopharm Theranostics complete a stock split?
Radiopharm Theranostics has not had any recent stock splits.
Where is Radiopharm Theranostics headquartered?
Radiopharm Theranostics is headquartered in Carlton, Australia.